Literature DB >> 11943960

High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure.

Hiroshi Sadamori1, Takahito Yagi, Masaru Inagaki, Yasuo Shima, Hiroaki Matsuda, Noriaki Tanaka, Kohsaku Sakaguchi, Takao Tsuji, Masaki Matsumi, Hiroshi Katayama, Norihisa Hirakawa.   

Abstract

In fulminant hepatic failure (FHF), rapidly progressive cerebral oedema remains the main fatal complication and an obstacle in liver transplantation. A 29-year-old Japanese woman presented with sudden-onset hepatic encephalopathy and jaundice. Hepatic encephalopathy deteriorated within 2 days of the onset of jaundice. She manifested extensory sustained clonus and was responsive only to pain. Diffuse cerebral oedema was noted on brain computerized tomography (CT) scan. Urgent living-donor liver transplantation (LDLT) at the time of admission was abandoned because of deterioration of neurological status and radiologically evident diffuse cerebral oedema. Instead, a high-flow-rate (7.2-9.0 l/h) haemodiafiltration with a high-performance membrane was commenced, combined with plasma exchange. This treatment regimen resulted in a gradual improvement of hepatic encephalopathy and complete disappearance of cerebral oedema within 7 days. Liver regeneration did not occur during this period, as evident by CT scan volumetry and serological tests. LDLT was subsequently performed using the right liver lobe of the patient's brother. Our case suggests that high-flow-rate haemodiafiltration with a high-performance membrane, combined with plasma exchange, could potentially be brain-support therapy for patients with FHF, and may contribute, when combined with liver transplantation, to the improvement of prognosis in hyperacute FHF.

Entities:  

Mesh:

Year:  2002        PMID: 11943960     DOI: 10.1097/00042737-200204000-00018

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Liver support systems: will they ever reach prime time?

Authors:  Rafael Bañares; María-Vega Catalina; Javier Vaquero
Journal:  Curr Gastroenterol Rep       Date:  2013-03

Review 2.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

3.  Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus).

Authors:  Ludwig Kramer; Edith Bauer; Peter Schenk; Rudolf Steininger; Marion Vigl; Reinhold Mallek
Journal:  Wien Klin Wochenschr       Date:  2003-09-15       Impact factor: 1.704

Review 4.  Extracorporeal renal and liver support in pediatric acute liver failure.

Authors:  Bogdana Sabina Zoica; Akash Deep
Journal:  Pediatr Nephrol       Date:  2020-06-05       Impact factor: 3.714

5.  A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems.

Authors:  Juan Lu; Xiaoqian Zhang; Jianzhou Li; Liang Yu; Ermei Chen; Danhua Zhu; Yimin Zhang; LanJuan Li
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.